Patent 9192112 was granted and assigned to Monsanto on November, 2015 by the United States Patent and Trademark Office.
This invention provides methods for producing a non-natural hybrid seed. Also disclosed are specific miRNAs and miRNA recognition sites useful for conferring inducible sterility on a crop plant, and recombinant DNA construct including such exogenous miRNA recognition sites.